RT Journal Article
SR Electronic
T1 Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.07.21260137
DO 10.1101/2021.07.07.21260137
A1 Klaser, Kerstin
A1 Thompson, Ellen J.
A1 Nguyen, Long H.
A1 Sudre, Carole H.
A1 Antonelli, Michela
A1 Murray, Benjamin
A1 Canas, Liane S.
A1 Molteni, Erika
A1 Graham, Mark S.
A1 Kerfoot, Eric
A1 Chen, Liyuan
A1 Deng, Jie
A1 May, Anna
A1 Hu, Christina
A1 Guest, Andy
A1 Selvachandran, Somesh
A1 Drew, David A
A1 Modat, Marc
A1 Chan, Andrew T.
A1 Wolf, Jonathan
A1 Spector, Tim D.
A1 Hammers, Alexander
A1 Duncan, Emma L.
A1 Ourselin, Sebastien
A1 Steves, Claire J.
YR 2021
UL http://medrxiv.org/content/early/2021/07/08/2021.07.07.21260137.abstract
AB Background Mental health issues have been reported after SARS-CoV-2 infection. However, comparison to prevalence in uninfected individuals and contribution from common risk factors (e.g., obesity, comorbidities) have not been examined. We identified how COVID-19 relates to mental health in the large community-based COVID Symptom Study.Methods We assessed anxiety and depression symptoms using two validated questionnaires in 413,148 individuals between February and April 2021; 26,998 had tested positive for SARS-CoV-2. We adjusted for physical and mental pre-pandemic comorbidities, BMI, age, and sex.Findings Overall, 26.4% of participants met screening criteria for general anxiety and depression. Anxiety and depression were slightly more prevalent in previously SARS-CoV-2 positive (30.4%) vs. negative (26.1%) individuals. This association was small compared to the effect of an unhealthy BMI and the presence of other comorbidities, and not evident in younger participants (≤40 years). Findings were robust to multiple sensitivity analyses. Association between SARS-CoV-2 infection and anxiety and depression was stronger in individuals with recent (<30 days) vs. more distant (>120 days) infection, suggesting a short-term effect.Interpretation A small association was identified between SARS-CoV-2 infection and anxiety and depression symptoms. The proportion meeting criteria for self-reported anxiety and depression disorders is only slightly higher than pre-pandemic.Funding Zoe Limited, National Institute for Health Research, Chronic Disease Research Foundation, National Institutes of Health, Medical Research Council UKCompeting Interest StatementAM, CH, AG, SS and JW are employees of Zoe Limited. TDS reports being a consultant for Zoe Limited, during the conduct of the study. ATC previously served as an investigator on a separate study supported by Zoe Limited. All other authors have nothing to declare. Funding StatementFunding: Zoe Limited, National Institute for Health Research, Chronic Disease Research Foundation, National Institutes of Health, Medical Research Council UK. This work is supported by the Wellcome Engineering and Physical Sciences Research Council (EPSRC) Centre for Medical Engineering at King's College London (WT203148/Z/16/Z) and the UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre (BRC) award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, the Medical Research Council (MRC) and British Heart Foundation. SO and MM are supported by the UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value Based Healthcare, and the Wellcome Flagship Programme (WT213038/Z/18/Z). This research was funded in part by the Wellcome Trust [WT213038/Z/18/Z] and [WT203148/Z/16/Z]. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. EM is funded by an MRC Skills Development Fellowship Scheme at KCL. CHS, EJT and CJS are supported by the National Core Studies, an initiative funded by UKRI, NIHR and the Health and Safety Executive, and funded by the Medical Research Council (MC_PC_20030). CHS is also supported by an Alzheimer's Society Junior Fellowship (AS-JF-17-011). Zoe Limited supported all aspects of building and running the app and service to all users worldwide. ATC is the Stuart and Suzanne Steele MGH Research Scholar. LHN is supported by an NIH K23DK125838 award, the American Gastroenterological Association Research Scholars Award, and the Crohn's and Colitis Foundation Career Development Award. DAD and LHN are supported by the AGA-Takeda COVID-19 Rapid Response Research Award (AGA2021-5102). DAD is supported by NIH/NIDDK K01DK120742. ATC, LHN, and DAD are supported by the Massachusetts Consortium on Pathogen Readiness (MassCPR). We express our sincere thanks to all the participant users of the app, including study volunteers enrolled in cohorts within the Coronavirus Pandemic Epidemiology (COPE) consortium.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for use of the app for research purposes in the UK was granted by the KCL Ethics Committee (review reference LRS-19/20-18210); all users provided consent for non-commercial use.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymised research data are shared with third parties via the centre for Health Data Research UK (HDRUK.ac.uk). US investigators are encouraged to coordinate data requests through the COPE Consortium (www.monganinstitute.org/cope-consortium). Data updates can be found on https://covid.joinzoe.com https://www.hdruk.ac.uk/ https://www.monganinstitute.org/cope-consortium https://covid.joinzoe.com